Skin Burn Or Open Wound Treatment Patents (Class 424/78.06)
-
Patent number: 8821848Abstract: A composition and method useful in promoting hemostasis, absorbing ooze, and being antimicrobial with respect to an open wound. The composition broadly includes an antimicrobial agent, preferably povidone iodine, preferably a ferrate compound, and a cation ion exchange resin. This composition will destroy a biofilm which has formed over the open wound in providing a soluble iron compound, a cation chelation compound, and an active antimicrobial compound effective against planktonic microorganisms and biofilms. The antimicrobial agent is locked or sealed within the scab formed over the wound to maintain long-term positioning and anti-dilution of the antimicrobial over the wound.Type: GrantFiled: December 20, 2012Date of Patent: September 2, 2014Assignee: Biolife, L.L.C.Inventors: Talmadge Kelly Keene, John Hen
-
Publication number: 20140242023Abstract: The present invention relates generally to topical compositions and methods of using the same.Type: ApplicationFiled: February 27, 2014Publication date: August 28, 2014Applicant: Novan, Inc.Inventors: Ryan Doxey, Adam Sabouni, Eleftherios Kougoulos, Nathan Stasko
-
Patent number: 8802073Abstract: Glycerophosphate salts have been found to hasten the healing of wounds and minimize the formation of scars, particularly when it is first applied to a wound about 0 to about 7 days after the wound is inflicted. Methods and compositions are provided for treating wounds using a composition comprising an effective amount of glycerophosphate salt. In particular, methods are provided for treating wounds using calcium glycerophosphate (CGP), for accelerating the healing process, reducing pain and scar formation, and for the cosmetic reducing, excision, erasure and/or complete repair of scars (scar revision).Type: GrantFiled: November 12, 2008Date of Patent: August 12, 2014Assignee: Prelief Inc.Inventor: Alan E. Kligerman
-
Patent number: 8784790Abstract: Chronic wounds may be treated by debriding necrotic and other devitalized tissue from the wound, and applying to the wound an extracellular polymeric substance solvating system comprising a metal ion sequestering agent, surfactant and buffering agent. The solvating system disrupts biofilms which may be present in the wound and aids or enables the resumption of normal healing.Type: GrantFiled: June 11, 2009Date of Patent: July 22, 2014Assignee: Medtronic Xomed, Inc.Inventors: Matthew F. Myntti, Dana A. Oliver, James B. Hissong, Jennifer G. Medina
-
Publication number: 20140186289Abstract: A sterilized cyanoacrylate adhesive composition including a cyanoacrylate composition and a cure speed enhancer, wherein said sterilized cyanoacrylate adhesive composition does not cure upon sterilization, and wherein the composition when cured to form a film on a patient's tissue has water vapor transmission rate from about 950 to about 3000 g/m2/day.Type: ApplicationFiled: November 22, 2013Publication date: July 3, 2014Applicant: Adhezion Biomedical, LLCInventors: Sheng Zhang, Rafael Ruiz, Sr., Max Azevedo
-
Publication number: 20140186415Abstract: A polymer composition including a polymer having a hydroxyl group and a histidine or a histidine derivative grafted to the polymer having a hydroxyl group. A polymer material is also provided, including a polymer composition which includes a polymer having a hydroxyl group, and a histidine or a histidine derivative grafted to the polymer having a hydroxyl group.Type: ApplicationFiled: December 18, 2013Publication date: July 3, 2014Applicant: Industrial Technology Research InstituteInventors: Ting-Yu SHIH, Tse-Min TENG, Chia-Chun WANG, Yu-Hua CHEN, Jui-Hsiang CHEN, Mei-Ju YANG, Shu-Fang CHIANG, Yen-Chun CHEN, Chia-Ni CHANG
-
Patent number: 8759300Abstract: Described herein are fragments of fibronectin and vitronectin and variants thereof that have certain activities, including growth factor-binding activity. Also described are fragments of growth factors that bind to fibronectin and inhibit binding of full-length growth factors to fibronectin. Compositions containing such fragments are useful in cosmetic treatments (e.g., the treatment of wrinkles or UV photodamage of skin), and the treatment of wounds and cancer.Type: GrantFiled: June 16, 2008Date of Patent: June 24, 2014Assignee: The Research Foundation for the State University of New YorkInventor: Richard A. Clark
-
Patent number: 8758738Abstract: The present invention relates to compositions of cyanoacrylate monomer, a method of improving the viscosity and the curing speed with a single additive and a process of providing sterilized cyanoacrylate adhesive compositions for application in the medical field.Type: GrantFiled: November 1, 2013Date of Patent: June 24, 2014Assignee: Adhezion Biomedical, LLCInventors: Sheng Zhang, Rafael Ruiz, Sr.
-
Publication number: 20140161761Abstract: Biocompatible phase invertible proteinaceous compositions and methods for making and using the same are provided. The subject phase invertible compositions are prepared by combining a crosslinker and a proteinaceous substrate. The proteinaceous substrate includes one or more proteins and a polyamine, where the polyamine and a proteinaceous substrate are present in synergistic viscosity enhancing amounts, and may also include one or more of: a carbohydrate, a tackifying agent, a plasticizer, or other modification agent. In certain embodiments, the crosslinker is a heat-treated dialdehyde, e.g., heat-treated glutaraldehyde. Also provided are kits for use in preparing the subject compositions. The subject compositions, kits and systems find use in a variety of different applications.Type: ApplicationFiled: February 11, 2014Publication date: June 12, 2014Applicant: Tenaxis Medical, Inc.Inventors: Ian J. Handley, Joanna Wong
-
Patent number: 8747830Abstract: The invention provides a dressing composition comprising a bisphosphonate matrix metalloproteinase (MMP) inhibitor covalently bound to a polymer wherein, when the dressing is contacted with a wound, substantially all of the bisphosphonate remains with the dressing composition and is unable to enter the wound tissue. The invention also provides for a method of treatment of a wound by contacting a dressing composition comprising a covalently bound MMP inhibitor with the wound fluid to thereby selectively inhibit one or more MMP's in the wound fluid without inhibiting those in the wound tissue.Type: GrantFiled: June 10, 2008Date of Patent: June 10, 2014Assignee: Queensland University of TechnologyInventors: Erin A. Rayment, Tim Dargaville, Zee Upton
-
Publication number: 20140120052Abstract: A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when applied over blood, provides an antimicrobial against planktonic microorganisms and biofilms in the wound. The resin is also capable, when applied in sufficient quantities, of providing a continuing and persistent antimicrobial against planktonic microorganisms and biofilms through dehydration and ion exchange with cations present in the blood and other body fluids. When the resin has a concentration of at least 26 mg/ml, it provides a >3 log reduction in biological activity of MRSA, MRSE and Pseudomonas aeruginosa.Type: ApplicationFiled: January 3, 2014Publication date: May 1, 2014Applicant: BIOLIFE, LLCInventors: JOHN HEN, JOHN ALFRED THOMPSON, TALMADGE KELLY KEENE, MARK TRAVI
-
Patent number: 8709393Abstract: The present invention relates to methods and compositions for wound healing. In particular, the present invention relates to promoting and enhancing wound healing by utilizing cross-linker covalent modification molecules to attach and deliver wound active agents to a wound. In addition, the present invention provides methods and compositions utilizing oppositely charged polymers to form a polyelectrolyte layer on a wound surface. The invention further relates to incorporating wound active agents into a polyelectrolyte layer for delivery to a wound.Type: GrantFiled: January 30, 2009Date of Patent: April 29, 2014Assignee: Wound Engineering LLCInventors: Jonathan F. McAnulty, Christopher Murphy, Nicholas Abbott
-
Patent number: 8709391Abstract: A method may include treating pain, shock, and/or inflammatory conditions in a subject. A method may include using a therapeutically effective amount of an antibody, a lipoxygenase inhibitor, a cytochrome P-450 enzyme inhibitor, and/or an antioxidant configurable to at least partially treat pain, shock, and/or inflammatory conditions in a subject. A method of treating pain, shock, and/or inflammatory conditions in a subject may include inactivating or preventing at least one linoleic acid metabolite to treat certain conditions (e.g., pain, shock, and/or inflammation).Type: GrantFiled: November 24, 2009Date of Patent: April 29, 2014Assignee: Board of Regents of the University of Texas SystemInventors: Amol Madhusudan Patwardhan, Kenneth Michael Hargreaves, Armen Norakovich Akopian
-
Patent number: 8709480Abstract: A method of in-situ adhering including providing pre-gel including phenolic compound and water miscible polymers like carbohydrates, salts of anionic polysaccharide, spreading layer of pre-gel onto a surface, adding solid support, comprising cross linking agents capable of interacting with the polymer, to pre-gel, and allowing pre-gel to cure and adhere onto surface.Type: GrantFiled: November 5, 2008Date of Patent: April 29, 2014Assignee: Technion Research and Development Foundation Ltd.Inventors: Havazelet Bianco-Peled, Ohad Kimhi
-
Patent number: 8709439Abstract: The invention provides a biological dressing for treatment of a dermatological disease comprised of one or more resins or other film-forming agents, a topically acceptable volatile solvent, and a pharmacologically active agent. The combined one or more resins are present in a suitable amount such that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the skin, nail or mucosal membrane to which the composition is applied, and maintain the pharmacologically active agent over a sustained period of time in contact with sites on the skin or mucosal membranes exhibiting symptoms of the disease. Methods are provided for treating symptoms of dermatological diseases with such a pharmacological composition.Type: GrantFiled: July 30, 2008Date of Patent: April 29, 2014Assignee: Jaleva Pharmaceuticals, LLCInventor: Alex Battaglia
-
Patent number: 8691203Abstract: The present inventions in various aspects provide elastic biodegradable polymers. In various embodiments, the polymers are formed by the reaction of a multifunctional alcohol or ether and a difunctional or higher order acid to form a pre-polymer, which is cross-linked to form the elastic biodegradable polymer. In preferred embodiments, the cross-linking is performed by functionalization of one or more OR groups on the pre-polymer backbone with vinyl, followed by photopolymerization to form the elastic biodegradable polymer composition or material. Preferably, acrylate is used to add one or more vinyls to the backbone of the pre-polymer to form an acrylated pre-polymer. In various embodiments, acrylated pre-polymers are co-polymerized with one or more acrylated co-polymers.Type: GrantFiled: March 23, 2012Date of Patent: April 8, 2014Assignee: Massachusetts Institute of TechnologyInventors: Christopher J. Bettinger, Joost P. Bruggeman, Lino Da Silva Ferreira, Jeffrey M. Karp, Robert S. Langer, Christiaan Nijst, Andreas Zumbuehl, Jason Burdick, Sonia J. Kim
-
Patent number: 8685381Abstract: The invention provides skin protecting and penetrating, easy-to-administer base and active agent-containing compositions, such as those including hydrocortisone, for treating the skin of mammals for different dermatologic disorders. This is effected by topically administering effective amounts of the compositions thereto in forms that address the skin and mucosa of the mouth and lips, and the rest of the body. Additionally, an optional flavoring addition to these products affords significantly better tasting, and less bitter, compositions, allowing a more pleasant experience and better compliance by patients. The compositions include a unique formulation of FANCOL VB, Natunola Castor 1023, Finsolv TN, bees wax and, optionally, one or a plurality of plant or plant seed oils, fatty alcohols, fats and flavorings, in desirable weight percents thereof, in various forms, and preferably in a form of a solid roll-on stick in a variety of sizes and of a jar or pot.Type: GrantFiled: September 14, 2011Date of Patent: April 1, 2014Inventors: Joel Schlessinger, Daniel Isaac Schlessinger
-
Publication number: 20140079661Abstract: It is provided new adhesive compositions comprising three components, compounds of formula (I), (II) and (III), namely, alkyl cyanoacrylates, alkyl carboxyacrylates and acrylates. It is also provided said compositions for use in medicine and veterinary, as bioadhesives.Type: ApplicationFiled: April 3, 2012Publication date: March 20, 2014Applicant: BIOADHESIVES MEDTECH SOLUTIONS, S.L.Inventors: José Miguel Martín Martínez, Manuel Martínez Paino, Luis Esteban Domínguez Arribas, Ana Villarreal Gómez
-
Patent number: 8673354Abstract: A composition including pre-gel including at least one phenol-based compound, excluding phloroglucinol and derivatives, at least one water miscible polymer, at least one cross linking agent capable of interacting with the polymer. The polymer is selected from one or more natural and/or synthetic carbohydrate, and salt of an anionic polysaccharide.Type: GrantFiled: November 5, 2008Date of Patent: March 18, 2014Assignee: Technion Research and Development Foundation Ltd.Inventors: Havazelet Bianco-Peled, Ohad Kimhi
-
Publication number: 20140072614Abstract: Compositions, methods, and kits are provided for sealing applications. Compositions are prepared by combining a first cross-linkable component with a second cross-linkable component to form a porous matrix having interstices, and combining the porous matrix with a hydrogel-forming component to fill at least some of the interstices. The compositions exhibit minimal swelling properties.Type: ApplicationFiled: February 28, 2013Publication date: March 13, 2014Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.Inventors: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
-
Publication number: 20140065091Abstract: The present invention relates to a polyurea system comprising as component A) isocyanate-functional prepolymers obtainable by reaction of aliphatic isocyanates A1) with polyols A2), which in particular can have a number-average molecular weight of ?400 g/mol and a mean OH functionality of from 2 to 6, as component B) an amino-functional compound of the general formula (I) in which X is an organic radical containing a secondary amino function, Y is an organic radical that contains a tertiary amino group and does not contain Zerewitinoff-active hydrogen, R1 is a CH2—COOR3 radical in which R3 is an organic radical that does not contain Zerewitinoff-active hydrogen, a linear or branched C1- to C4-alkyl radical, a cyclopentyl radical, a cyclohexyl radical or H, R2 is an organic radical that does not contain Zerewitinoff-active hydrogen, a is 1 or 2, b is 1 or 2, and a+b=2 or 3, for stemming the escape of blood, and to a metering system for the polyurea system according to the invention.Type: ApplicationFiled: April 17, 2012Publication date: March 6, 2014Applicant: BAYER INTELLECTUAL PROPERTY GMBHInventors: Heike Heckroth, Christoph Eggert
-
Publication number: 20140065092Abstract: The subject of the present invention is yarns, fibers or filaments and also a textile article and a medical device obtained from said yarns, for improving skin cicatrization, in particular by activating collagen synthesis at the surface of the injured skin. The yarns, fibers or filaments of the invention comprise a polymeric matrix and inorganic fillers, uniformly dispersed in the polymeric matrix, having properties of absorption and/or of emission in the 2-20 ?m far-infrared region.Type: ApplicationFiled: May 16, 2012Publication date: March 6, 2014Applicant: RHODIA POLIAMIDA E ESPECIALIDADES LTDAInventors: Tarcis Cordeiro Bastos, Gabriel Gorescu, Thomas Canova
-
Publication number: 20140065090Abstract: Materials capable of delivering stabilized free radicals to targeted treatment sites. The materials comprise semi-crystalline, hydrolytically degradable polymers that are subjected to ionizing radiation to create stabilized free radicals therein. Upon exposure to oxygen containing aqueous media, the materials generate reactive oxidative species which are useful in biological processes.Type: ApplicationFiled: August 29, 2013Publication date: March 6, 2014Applicant: W. L. Gore & Associates, Inc.Inventors: Tiffany J. Brown, Adam S. Lafleur, Kenneth Mazich, Jeffrey C. Towler, Ji Zhang
-
Patent number: 8664280Abstract: A kit for forming a bioerodible composition is provided with a first aliquot portion of a reaction mixture having an aldehydic polymer solution, and a second aliquot portion of a reaction mixture having solids which include a cross-linking hydrazide. When mixed, the first and second aliquot portions of the reaction mixture react at a pH of 4 to 6 to form a solidified bioerodible composition within about 1 to about 10 minutes, to form a hydrazide cross-linked aldehydic polymer matrix. The bioerodable composition may be usefully employed to seal and/or treat wounds (e.g., a surgical incision).Type: GrantFiled: April 22, 2013Date of Patent: March 4, 2014Assignee: Royer Biomedical, Inc.Inventor: Garfield P. Royer
-
Patent number: 8663617Abstract: The current invention relates to methods and compositions for the treatment of wounds in a mammalian subject. Particularly, the invention relates to novel polypeptides and encoding nucleic acids that stimulate keratinocyte and endothelial cell motility and/or proliferation.Type: GrantFiled: October 16, 2012Date of Patent: March 4, 2014Assignee: Tufts UniversityInventor: Ira M Herman
-
Publication number: 20140056839Abstract: The present invention relates to compositions of cyanoacrylate monomer, a method of improving the viscosity and the curing speed with a single additive and a process of providing sterilized cyanoacrylate adhesive compositions for application in the medical field.Type: ApplicationFiled: November 1, 2013Publication date: February 27, 2014Applicant: Adhezion Biomedical, LLCInventors: Sheng Zhang, Rafael Ruiz, SR.
-
Patent number: 8658625Abstract: External preparations for treatment of painful skin wound having an analgesic activity which comprises acetylsalicylic acid or its pharmacologically acceptable salt as an active ingredient.Type: GrantFiled: February 16, 2004Date of Patent: February 25, 2014Assignee: Teikoku Seiyaku Co., Ltd.Inventors: Yukiko Inamoto, Mitsuhiro Kawada, Akihiro Hasui, Kenichi Hattori
-
Patent number: 8636988Abstract: A composition for treatment of burned or irritated skin. The composition includes an anesthetic component comprising lidocaine, an anti-inflammatory component comprising hydrocortisone, an emollient comprising aloe vera, and a pharmaceutically acceptable base. The resulting composition has a cream like consistency. Upon application to the skin, there is no slimy or sticky residue, but the composition becomes nearly dry to the touch. It exhibits a smooth, silk like feel once applied. When applied to an area of burned or irritated skin, the pain immediately subsides, and in the case of sunburn, there is a noticeable tendency for the composition to reduce or eliminate peeling of the skin as the sunburn heals.Type: GrantFiled: February 2, 2009Date of Patent: January 28, 2014Assignee: Doctor EssentialsInventor: Angela L. Lorenzo
-
Publication number: 20140023610Abstract: This invention is a composition comprising a cyclic siloxane, a silicone occlusive fluid, a silicone occlusive gel, and a silicone resin powder. The composition is useful for wound healing.Type: ApplicationFiled: September 19, 2013Publication date: January 23, 2014Applicant: VALEANT PHARMACEUTICALS INTERNATIONALInventors: Irwin PALEFSKY, Ni'Kita WILSON
-
Patent number: 8623334Abstract: A topical anesthetic is provided containing about 3 wt % to 10 wt % tetracaine in a vehicle suitable for administration to the mucosa. The vehicle for transporting the tetracaine includes a water soluble mucoadhesive or a combination of mucoadhesives such as a high molecular weight poly(ethylene oxide) homopolymer and a cellulose polymer. The vehicle also includes propylene glycol. The tetracaine is ground into a powder and is suspended in a plasticized hydrocarbon gel which completes the vehicle.Type: GrantFiled: September 10, 2012Date of Patent: January 7, 2014Inventors: Alan J. Wickenhauser, Stephen E. Peipert
-
Publication number: 20130337036Abstract: Disclosed herein is a fibrous tissue sealant in the form of an anhydrous fibrous sheet comprising a first component which is a fibrous polymer containing electrophilic or nucleophilic groups and a second component capable of crosslinking the first component when the sheet is exposed to an aqueous medium, thereby forming a crosslinked hydrogel that is adhesive to biological tissue. The fibrous tissue sealant may be useful as a general tissue adhesive for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures, tissue repair, and to prevent post-surgical adhesions. The fibrous tissue sealant may be particularly suitable for use as a hemostatic sealant to stanch bleeding from surgical or traumatic wounds.Type: ApplicationFiled: August 16, 2013Publication date: December 19, 2013Applicant: Actamax Surgical Materials, LLCInventors: Samuel David Arthur, Tao Huang, William Gerald Dimaio, JR., George K. Kodokian
-
Publication number: 20130337042Abstract: The invention concerns a method for the production of a pharmaceutical preparation for the treatment of Herpes forms that is characterized in, that the preparation comprises at least one antiseptic compound associated with a particular carrier.Type: ApplicationFiled: May 28, 2013Publication date: December 19, 2013Applicant: Euro-Celtique, S.A.Inventors: Karen REIMER, Wolfgang Fleischer
-
Publication number: 20130323195Abstract: A plurality of fibers or one-dimensional, two-dimensional, or three-dimensional fibrous structures are provided, having fibers from a first raw fiber material. The first raw fiber material contains unsubstituted or partially substituted polyvinyl alcohol and/or unsubstituted or partially substituted polyvinyl alcohol copolymer. The fibers can be crosslinked by tempering the fibers or fibrous structures, with the result that the fibers or the fibrous structure are configured to be gel, in particular hydrogel, fibers or fibrous structures and have excellent stability.Type: ApplicationFiled: July 29, 2011Publication date: December 5, 2013Applicant: CARL FREUDENBERG KGInventors: Wiebke Schmitz, Julia Schmidt, Bernd Schlesselmann, Gunter Scharfenberger
-
Patent number: 8580239Abstract: The present invention provides skin grafting and devices that comprise a systematic approach to the process of skin grafting, i.e., harvesting, post-excision processing and application of donor skin and pre and post-graft treatment of the recipient site.Type: GrantFiled: January 27, 2010Date of Patent: November 12, 2013Assignee: KCI Licensing, Inc.Inventors: Charles Seegert, Royce W. Johnson, A. David Boccuti, Andrew Nicholas Gentile, Sy Griffey, Teryl Blane Sanders
-
Patent number: 8574609Abstract: Broad spectrum disinfecting and microbicidal compositions of biodegradable and environmentally friendly compositions containing esters formed from fatty organic alcohols and fatty carboxylic acids. These compositions display activities against the most resistant microbial forms including bacterial spores. The preparations can be used in health care, food processing, personal care and other industries where the use of harsh oxidizing chemicals is undesirable.Type: GrantFiled: May 2, 2011Date of Patent: November 5, 2013Inventor: John Alex Lopes
-
Patent number: 8563604Abstract: This invention is a composition comprising a cyclic siloxane, a silicone occlusive fluid, a silicone occlusive gel, and a silicone resin powder. The composition is useful for wound healing.Type: GrantFiled: September 30, 2008Date of Patent: October 22, 2013Assignee: Valeant Pharmaceuticals InternationalInventors: Irwin Palefsky, Ni'Kita Wilson
-
Patent number: 8552135Abstract: Linear polydialkoxysiloxanes with 2-8 polymeric units have been reacted with alcohols by a transetherification reaction to provide hydrophilic and water soluble silicone products. The glycerol substituted siloxanes in particular are effective in topically treating skin lesions such as radiation burns. Compositions including the substituted polydialkoxysiloxane products inhibit biofilm formation when used as coatings on hard surfaces.Type: GrantFiled: April 13, 2012Date of Patent: October 8, 2013Assignee: One Unlimited, Inc.Inventor: Leonard William Luria
-
Publication number: 20130251665Abstract: The invention provides a method of treating a wound (for example, a chronic ulcerous skin lesion) in a human or non-human mammal (particularly a human). The wound is contacted with a topical hydrogel composition comprising a hydrophilic polymer carrying multiple pendant sulphonyl groups, optionally with multiple pendant carboxylic groups, on each polymer molecule.Type: ApplicationFiled: May 24, 2013Publication date: September 26, 2013Applicant: FIRST WATER LIMITEDInventor: Hugh Semple Munro
-
Patent number: 8540976Abstract: A poly(non-conjugated diene) based sunscreen has a plurality of repeating units where each repeating unit has at least one UV absorbing chromophore that is situated between and connected by chains to two mono-ene units where each UV absorbing chromophore absorb UVA and UVB light. The poly(non-conjugated diene) based sunscreen can be included with a vehicle for application to the skin to prevent sunburn. The poly(non-conjugated diene) based sunscreen can be prepared by acyclic diene metathesis polymerization.Type: GrantFiled: April 1, 2010Date of Patent: September 24, 2013Assignee: University of Florida Research Foundation, Inc.Inventors: James Klein Leonard, Kenneth Berry Sloan, Kenneth Boone Wagener
-
Patent number: 8512718Abstract: A pharmaceutical or cosmetic carrier or composition for topical application characterized by rheological properties which render the carrier or composition semi-solid at rest and a liquid upon application of shear forces thereto. The composition or carrier are prepared by mixing 1-25 percent of a solidifying agent and 75-99 percent of a hydrophobic solvent, by weight, wherein at least one of them has therapeutic or cosmetic benefits, in the presence or absence of a biologically active substance.Type: GrantFiled: February 12, 2010Date of Patent: August 20, 2013Assignee: Foamix Ltd.Inventors: Meir Eini, Dov Tamarkin
-
Patent number: 8491881Abstract: A biological coating material that includes a polymerizable polyacrylate monomer; a volatile liquid; a polymer selected from a synthetic rubber, a natural rubber, and a thermoplastic elastomer. The biological liquid coating material forms a coating or bandage in the form of a film that when applied and adhered to a surface or to the skin of a user inhibits the application surface from adhering to another surface.Type: GrantFiled: April 30, 2012Date of Patent: July 23, 2013Assignee: Rochal Industries, LLPInventors: Ann Beal Salamone, Joseph C. Salamone
-
Patent number: 8486454Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic pain in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic pain.Type: GrantFiled: September 29, 2006Date of Patent: July 16, 2013Assignee: Sessions Pharmaceuticals Inc.Inventors: Robert W. Sessions, Alan R. Kahn
-
Patent number: 8486375Abstract: The present invention is related to a foamable composition of matter comprising iodine, water, a foam adjuvant, a surface-active agent and a gelling agent. This foamable composition, which may be provided in a propellant free foaming device, or alternatively may further comprise a propellant, evolves into foam, which is effective in the topical treatment and prevention of various skin disorders.Type: GrantFiled: February 20, 2012Date of Patent: July 16, 2013Assignee: Foamix Ltd.Inventors: Dov Tamarkin, Doron Friedman, Meir Eini
-
Publication number: 20130165838Abstract: The present invention relates to a wound dressing which comprises a hydrocolloid adhesive mass comprising a hydrophobic elastomer matrix comprising poly(styrene-olefin-styrene) block copolymers, particles of hydrocolloid(s) dispersed in said elastomer matrix, and at least one tackifying hydrocarbon resin, characterized in that the hydrocolloid adhesive mass has a deformation ratio ? comprised between at least 0.10 and at most 0.40, as measured by subjecting a cylindrical sample having a diameter of 10 mm, of said hydrocolloid adhesive mass having a thickness of 1.0 mm, at a temperature of 37° C.Type: ApplicationFiled: April 27, 2011Publication date: June 27, 2013Applicant: LABORATOIRES URGOInventors: Stephane Auguste, Cecile Richard, Sebastien Renard, Serge Lecomte, Christelle Guillamaud
-
Publication number: 20130156824Abstract: The present invention provides a wound dressing comprising a tessellated water-soluble molding matrix comprised of a polymer selected from the group consisting of polyvinyl alcohol, gelatin, and mixtures thereof and a 1,1-disubstituted ethylene monomer. The present invention further provides methods of using the wound dressing and kits containing the wound dressing.Type: ApplicationFiled: February 15, 2013Publication date: June 20, 2013Applicant: ETHICON, INC.Inventor: ETHICON, INC.
-
Methods And Kits For Treating Lacerations And Puncture Wounds Using Inverse Thermosensitive Polymers
Publication number: 20130158589Abstract: In certain embodiments, the present invention relates to methods and kits for treating wounds, comprising the step of introducing into said wound a composition comprising at least one optionally purified inverse thermosensitive polymer, wherein said at least one optionally purified inverse thermosensitive polymer forms a gel in said wound, thereby temporarily occluding said wound. In certain embodiments, the present invention relates to the aforementioned method wherein a wound to a blood vessel or a segment of the GI tract is occluded, thereby preventing exsanguination and/or septicemia. In other embodiments, the inventive methods and kits described herein may be used to ameliorate (e.g., fill) temporarily a defect in a biological lumen, thereby strengthening said defect, preventing rupture of, or maintaining, improving or optimizing fluid flow through said lumen.Type: ApplicationFiled: February 13, 2013Publication date: June 20, 2013Applicant: PLUROMED, INC.Inventor: Pluromed, Inc. -
Publication number: 20130150652Abstract: A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.Type: ApplicationFiled: February 6, 2013Publication date: June 13, 2013Applicant: BIOLIFE, L.L.C.Inventor: BIOLIFE, L.L.C.
-
Publication number: 20130136715Abstract: A monomeric adhesive composition includes a stabilized polymerizable monomer, such as a 1,1-disubstituted monomer, including a cyanoacrylate, and a wound healing agent, wherein the wound healing agent is 5,5-disubstitutedhydantoin, including phenytoin; and a method for making said composition.Type: ApplicationFiled: August 9, 2011Publication date: May 30, 2013Applicant: ADHEZION BIOMEDICAL, LLCInventors: Sheng Zhang, Rafael Ruiz, SR.
-
Publication number: 20130121952Abstract: The present invention provides a hydrogel composition, preferably for the treatment of wounds, comprising a hydrophilic co-polymer carrying multiple pendant anionic groups, wherein the polymer is derived from a first monomer and a second monomer, wherein both monomers have an octanol:water partition coefficient Log P value of less than 0, and, the Log P value of the first monomer is greater (more positive) than the second monomer. The difference between the Log P value for the two monomers is preferably less than 2. The weight ratio (w/w) of the first monomer/second monomer in the hydrogel composition is preferably equal to or more than about 1. The pendant anionic groups may be sulphonyl groups, e.g. sulphonic acid groups or salts thereof. The anionic group in both first and second monomers may be in salt form and the counterion for both monomers is preferably the same.Type: ApplicationFiled: January 4, 2013Publication date: May 16, 2013Applicant: FIRST WATER LIMITEDInventor: FIRST WATER LIMITED
-
Patent number: 8440227Abstract: A biological adhesive formulation comprising dextrin, at least one adhesiveness modifier agent, and at least one antibiotic is suitable for promoting healing of tissue in a patient, for example, to prevent anastomosis of a surgical wound in the digestive system of a patient, and for affixing prosthesis during a hernia operation in a patient and occluding a fistula within a patient.Type: GrantFiled: April 23, 2012Date of Patent: May 14, 2013Inventor: Jorge Cueto-Garcia